This page has been archived.
Information identified as archived on the Web is for reference, research or recordkeeping purposes. It has not been altered or updated after the date of archiving. Web pages that are archived on the Web are not subject to the Government of Canada Web Standards. As per the Communications Policy of the Government of Canada, you can request alternate formats on the "Contact Us" page.
Management Representation Statement
Overall Departmental Performance
SECTION II - ANALYSIS OF THE PROGRAM ACTIVITY BY STRATEGIC OUTCOME
Priority 1: Compliance and Enforcement
Priority 2: Report on Pharmaceutical Trends
SECTION III - SUPPLEMENTARY INFORMATION
Financial Table 1: Comparison of Planned to Actual Spending (including FTEs)
Financial Table 2: Voted and Statutory Items
Financial Table 3: Sources of Non-Respendable Revenue
Financial Table 4: Financial Statements of the Patented Medicine Prices Review Board
SECTION IV - OTHER ITEMS OF INTEREST